What exactly is bladder cancer in dogs, and which type is most common?

Most canine bladder tumors are transitional cell carcinoma (TCC), also called urothelial carcinoma, which arises from the transitional epithelial cells lining the inside of the bladder. The Merck Veterinary Manual notes that TCC accounts for roughly two-thirds of all lower urinary tract tumors in dogs and typically develops at the trigone, the triangular region where the ureters enter and the urethra exits the bladder, which is exactly the location most likely to cause obstruction (Merck Veterinary Manual, 2024).

Because tumors form at this chokepoint, even a small mass can partially block urine flow long before it's large enough to feel on an abdominal exam. TCC is also locally invasive, meaning it tends to grow into the muscular wall of the bladder and nearby structures like the prostate or urethra rather than staying confined to the lining, and the Cornell Riney Canine Health Center reports that by the time of diagnosis, a substantial proportion of dogs already have microscopic or visible spread to regional lymph nodes, lungs, or bone (Cornell Riney Canine Health Center, n.d.).

What are the first symptoms owners notice at home?

The earliest and most consistent signs are blood in the urine (hematuria), straining to urinate (stranguria), and urinating more frequently in small amounts — a symptom cluster nearly identical to a routine bacterial urinary tract infection. The American Veterinary Medical Association points out that this overlap is precisely why bladder cancer is so often missed initially, since many dogs are treated with one or more courses of antibiotics before anyone considers imaging the bladder (American Veterinary Medical Association, n.d.).

A pattern that should raise suspicion is urinary symptoms that improve briefly on antibiotics and then return, or persist despite a negative urine culture. Some dogs also develop partial urinary obstruction, straining hard but producing only a dribble, which can progress to a life-threatening complete blockage within days if the tumor has grown across the urethral opening.

Why do some dogs get bladder cancer and others don't?

Breed is the single strongest known risk factor. Scottish Terriers are reported to have roughly 18 to 20 times the risk of TCC compared with mixed-breed dogs, and West Highland White Terriers, Shetland Sheepdogs, Beagles, and Wire Fox Terriers also show clearly elevated rates, according to research summarized by the AKC Canine Health Foundation (AKC Canine Health Foundation, n.d.).

Environmental exposure compounds genetic risk. Studies cited by veterinary oncology researchers have linked older-generation flea and tick dips containing organophosphates, along with exposure to lawn herbicides and pesticides such as older phenoxy-acid weed killers, to higher bladder cancer incidence in predisposed breeds, and obesity has separately been identified as an independent risk factor in Scottish Terriers specifically (Merck Veterinary Manual, 2024). Most affected dogs are older, typically diagnosed between 9 and 11 years of age.

How do vets figure out it's cancer and not just an infection?

Diagnosis usually starts with abdominal ultrasound, which can reveal a thickened, irregular mass at the trigone that looks distinctly different from the diffuse wall thickening seen with chronic cystitis. Because traditional needle biopsy or catheter biopsy of a suspected TCC carries a small but real risk of seeding tumor cells along the needle tract, many veterinary oncologists now rely on a urine-based test called the CADET BRAF assay, which detects a specific BRAF gene mutation present in a large majority of canine TCC cases and can be run on a free-catch urine sample (Cornell Riney Canine Health Center, n.d.).

When more certainty is needed, vets use cystoscopy or ultrasound-guided catheter biopsy to obtain tissue for histopathology, and staging typically includes chest X-rays or CT to check for lung metastasis plus abdominal imaging to evaluate lymph nodes, since treatment recommendations and prognosis both hinge heavily on how far the disease has already spread at diagnosis.

What treatments actually help, and can bladder cancer be cured?

Complete surgical removal is rarely possible because trigonal tumors are so close to the ureteral and urethral openings that cutting them out risks leaving the dog unable to control urination or pass urine at all; surgery is generally reserved for the minority of tumors located away from the trigone. For most dogs, the mainstay is medical management combining a nonsteroidal anti-inflammatory drug, most often piroxicam, with chemotherapy agents such as mitoxantrone or vinblastine, a protocol shown in veterinary oncology studies to shrink or stabilize tumors in a meaningful proportion of dogs and extend median survival to roughly six to twelve months from diagnosis (Merck Veterinary Manual, 2024).

Piroxicam alone has documented anti-tumor activity in canine TCC beyond its role as a pain reliever, likely through COX-2 inhibition, and is frequently continued long-term even when chemotherapy is added. In dogs where the tumor obstructs urine outflow, a stent placed across the urethra or a tube cystostomy can relieve the blockage and preserve quality of life even when the cancer itself can't be eliminated. Because a true cure is uncommon, veterinary oncologists describe the goal of treatment as prolonging good-quality time rather than eradicating the disease.

How do I manage a dog with bladder cancer day to day?

Daily management centers on medication consistency, hydration, and close monitoring for signs of obstruction. Piroxicam is typically given with food to reduce gastrointestinal upset, and owners are usually asked to watch for vomiting, black stools, or reduced appetite, which can signal a GI ulcer, a known risk of long-term NSAID use that vets monitor with periodic bloodwork (American Animal Hospital Association, n.d.).

Encouraging frequent access to fresh water and more frequent bathroom breaks can reduce the concentration of irritating compounds sitting against the bladder wall and may modestly ease discomfort. Many owners also keep a simple daily log of urination frequency, straining, and appetite, since a sudden change — like a dog straining repeatedly and producing nothing — is often the first sign that the tumor has progressed enough to need a recheck sooner than scheduled.

What's the realistic long-term outlook for a dog diagnosed with this cancer?

Prognosis varies with tumor location, stage at diagnosis, and whether metastasis is already present, but overall median survival with combination medical therapy is commonly cited in the six-to-twelve-month range, with a smaller subset of dogs living well beyond a year when the tumor responds well and stays away from the trigone (Merck Veterinary Manual, 2024). Dogs with evidence of spread to lymph nodes or lungs at diagnosis generally have shorter survival times than those caught before metastasis is detectable.

Quality of life during treatment is often good for months at a time, particularly once any obstruction is addressed, which is why many veterinary oncologists frame the disease as manageable rather than immediately terminal. Regular rechecks, typically every 8 to 12 weeks with repeat ultrasound, help track tumor response and let the care team adjust medications before a dog reaches a crisis point.